The impact of EGFR-TKIs treatment on ground-glass opacity-featured lung adenocarcinama

This study reports a potentially effective postoperative treatment strategy for mGGOs. The EGFR - TKI therapy appears to be beneficial for GGO - featured lung adenocarcinoma patients. However, further research is required to determine the optimal timing and approach for maximizing the therapeutic effect. Based on our findings, EGFR - TKI therapy can be considered as a viable treatment option for eligible patients.